Antirheumatic Therapy: Actions and Outcomes

1. Medicinal chemistry of the disease modifying anti-rheumatic drugs
Garry G. Graham

2. Targeting DMARD therapy
Maria E. Suarez-Almazor

3. Pharmacoeconomic properties of disease-modifying antirheumatic drugs
Andreas Maetzel, Daniel H. Solomon

4. Future molecular targets
Edward C. Keystone, Boulos Haraoui

5. Hydroxychloroquine
Beau Bothwell, Daniel E. Furst

6. Sulfasalazine
Cees J. Haagsma

7. Parenteral gold
Rolf Rau

8. Azathioprine
David Kanel, Barry Bresnihan

9. Methotrexate
Kevin Pile

10. Leflunomide
Alberta Hoi, Geoffrey Littlejohn

11. Cyclosporin
Arno W. R. Kuijk, Ben A. C. Dijkmans

12. Tetracyclines
Kristin Bird, James R. O’Dell

13. Systemic glucocorticoids in rheumatoid arthritis
John R. Kirwan, Mark G. Perry

14. TNF-α inhibitors
Zuhre Tutuncu, Arthur Kavanaugh

15. Anakinra in rheumatoid arthritis
Barry Bresnihan

16. Combination therapy
Ernest Choy, Harold E. Paulus

17. Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases
Alan Tyndall, Jacob M. Laar

Keywords: Medicine & Public Health, Medicine/Public Health, general